Changes in levels of urinary estrogen metabolites after oral indole-3- carbinol treatment in humans

Journal of the National Cancer Institute

Volumn 89, Issue 10, 1997, Pages 718-723

  Michnovicz, Jon J ^a,d   Adlercreutz, Herman ^b   Bradlow, H Leon ^c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c STRANG CANCER PREVENTION CENTER   (United States)

^d Institute for Hormone Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; CYTOCHROME P450; ESTROGEN;

AEROBIC METABOLISM; ARTICLE; BREAST CANCER; CANCER PREVENTION; CLINICAL ARTICLE; DRUG EFFECT; ESTROGEN URINE LEVEL; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION;

EID: 0030954304     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.10.718     Document Type: Article

References (44)

1. Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, et al. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci U S A 1982;79:3047-51.
2. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC, Bradfield CA. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci U S A 1991;88:9543-7.
3. Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, Bradlow HL. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 1993;45:1129-36.
4. Klug TL, Bradlow HL, Sepkovic DW. Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2-and 16 alpha-hydroxyestrone in urine. Steroids 1994;59: 648-55.
5. Michnovicz JJ, Bradlow HL. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 1990;82:947-9.
6. Fotsis T, Adlercreutz H. The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS - I. Quantitation of estrogens after initial hydrolysis of conjugates. J Steroid Biochem 1987;28:203-13.
7. Wahala K, Brunow G, Hase T, Bannwart C, Adlercreutz H. Synthesis of deuterium labelled ethoxyamine for derivatization of estrogens as stable-isotope internal standards. Finnish Chem Lett 1987;14:198-201.
8. Bannwart C, Adlercreutz H, Wahala K, Brunow G, Hase T. Deuterium labelled ethoximes as stable isotope internal standards in the GC/MS-SIM determination of oxo-estrogens in human urine extracts: preliminary results. In: Gorog S, Heftmann E, editors. Advances in steroid analyses '87. Proceedings of the Symposium on the Analysis of Steroids, Sopron, Hungary. Budapest: Akademiai Kiado, 1988:283-6.
9. Chen C, Malone KE, Prunty J, Daling JR. Measurement of urinary estrogen metabolites using a monoclonal enzyme-linked immunoassay kit: assay performance and feasibility for epidemiological studies. Cancer Epidemiol Biomarkers Prev 1996;5:727-32.
10. Michnovicz JJ, Bradlow HL. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr Cancer 1991;16:59-66.
11. Bailey GS, Hendricks JD, Shelton DW, Nixon JE, Pawlowski NE. Enhancement of carcinogenesis by the natural anticarcinogen indole-3-carbinol. J Natl Cancer Inst 1987;78:931-4.
12. Ames BN, Profet M, Gold LS. Nature's chemicals and synthetic chemicals: comparative toxicology. Proc Natl Acad Sci U S A 1990;87: 7782-6.
13. Fishman J, Martucci C. Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab 1980;51:611-5.
14. Swaneck GE, Fishman J. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci U S A 1988; 85:7831-5.
15. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84: 634-8.
16. Martucci CP, Fishman J. Impact of continuously administered catechol estrogens in uterine growth and luteinizing hormone secretion. Endocrinology 1979;105:1288-92.
17. Vandewalle B, Lefebvre J. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 1989;61:239-46.
18. Schutze N, Vollmer G, Knuppen R. Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells. J Steroid Biochem Mol Biol 1994;48:453-61.
19. Michnovicz JJ. Plant estrogens and human health [editorial]. Ann Surg Oncol 1996;3:513-4.
20. Longcope C, Flood C, Femino A, Williams KI. Metabolism of 2-methoxyestrone in normal men. J Clin Endocrinol Metab 1983;57:277-82.
21. Hoffman AR, Paul SM, Axelrod J. Catecholestrogen synthesis and metabolism by human breast tumors in vitro. Cancer Res 1979;39: 4584-7.
22. Bradlow HL, Sepkovic DW, Telang NT, Osborne MP. Indole-3-carbinol. A novel approach to breast cancer prevention. Ann N Y Acad Sci 1995;768:180-200.
23. Schneider J, Bradlow HL, Strain G, Levin J, Anderson K, Fishman J. Effects of obesity on estradiol metabolism: decreased formation of nonuterotropic metabolites. J Clin Endocrinol Metab 1983;56:973-8.
24. Snow RC, Barbieri RL, Frisch RE. Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab 1989;69:369-76.
25. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E. Estrogen metabolism and excretion in Oriental and Caucasian women [published erratum appears in J Natl Cancer Inst 1995;18:147]. J Natl Cancer Inst 1994;86:1076-82.
26. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hockerstedt K, et al. Diet and urinary estrogen profiles in various populations. A preliminary report. Polycyclic Aromatic Compounds 1994:6;261-73.
27. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 1982;307:1542-7.
28. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
29. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991;2:427-42.
30. Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996;88:340-8.
31. Bradlow HL, Michnovicz JJ, Halper M, Miller DG, Wong GY, Osborne MP. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prev 1994;3:591-5.
32. Wattenberg LW. Inhibition of chemical carcinogenesis. J Natl Cancer Inst 1978;60:11-8.
33. Sharma S, Stutzman JD, Kelloff GJ, Steele VE. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res 1994;54:5848-55.
34. Safe SH. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Ther 1995;67:247-81.
35. Tiwari RK, Guo L, Bradlow HL, Telang NT, Osborne MP. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent. J Natl Cancer Inst 1994;86:126-31.
36. Dannan GA, Porubek DJ, Nelson SD, Waxman DJ, Guengerich FP. 17 beta-estradiol 2-and 4-hydroxylation catalyzed by rat hepatic cytochrome P-450: roles of individual forms, inductive effects, developmental patterns, and alterations by gonadectomy and hormone replacement. Endocrinology 1986;118:1952-60.
37. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys 1991;290:160-6.
38. Chen YH, Riby J, Srivastava P, Bartholomew J, Denison M, Bjeldanes L. Regulation of CYP1A1 by indolo[3,2-b]carbazole in murine hepatoma cells. J Biol Chem 1995;270:22548-55.
39. Taioli E, Trachman J, Chen X, Toniolo P, Garte SJ. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 1995;55:3757-8.
40. Taioli E, Bradlow HL, Sepkovic DW, Garbers S, Trachman J, Garte SJ. CYP1A1 genotype, estradiol metabolism and breast cancer in African-Americans. Proc Am Assoc Cancer Res 1996;37:249.
41. Woods MN, Barnett JB, Spiegelman D, Trail N, Hertzmark E, Longcope C, et al. Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst 1996;88:1369-74.
42. Taioli E, Garte SJ, Trachman J, Garbers S, Sepkovic DW, Osborne MP, et al. Ethnic differences in estrogen metabolism in healthy women [letter]. J Natl Cancer Inst 1996;88: 617.
43. Tabor MW, Coats E, Sainsbury M, Shertzer HG. Antioxidation potential of indole compounds - structure activity studies. Adv Exp Med Biol 1991;283:833-6.
44. Bradfield CA, Bjeldanes LF. Effect of dietary indole-3-carbinol on intestinal and hepatic monooxygenase glutathione 5-transferase and epoxide hydrolase activities in the rat. Food Chem Toxicol 1984;22:977-82.